Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c15203 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Ziyi Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing Universit…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Fatty Liver, Antioxidants, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
- The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, Beij…
ORCID-Profile: Heyun Shen
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Lin, Z., Xu, P., Xu, Y., Zheng, Y., Li, H., Chen, Z., Wang, Z., Song, S., Liu, Y., Yang, Z., Cui, J., & Shen, H. (2025). Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c15203
Vancouver
Lin Z, Xu P, Xu Y, Zheng Y, Li H, Chen Z, et al. Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c15203
BibTeX
@article{Lin2025,
author = {Lin, Ziyi and Xu, Peng and Xu, Yuehai and Zheng, Yixin and Li, Huimin and Chen, Zixin and Wang, Zhe and Song, Shaochen and Liu, Yuhao and Yang, Zhao and Cui, Ju and Shen, Heyun},
title = {Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c15203}
}
EUVIMED